Aquinox Pharmaceuticals Initiates Patient Dosing in the Phase 2 Clinical Trial …
… pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, announced today that it has initiated dosing in a Phase 2 clinical trial of AQX-1125 for the treatment of atopic …
Read more on Virtual-Strategy Magazine (press release)
Sanofi Faces Serious Competitive Challenges: Is It Time To Buy Or Sell? (SNY)
Sanofi and its partner Regeneron (NASDAQ:REGN) are conducting a Phase 3 study for dupilumab, the first biologic investigational therapy for moderate-to-severe atopic dermatitis. The market for moderate-to-severe atopic dermatitis is large, as dupilumab …
Read more on Seeking Alpha
Topical steroid cream improves dermatitis in cancer patients
A recent study found that a topical steroid cream frequently used to treat common skin conditions, can be used to improve dermatitis in cancer patients. The trial of this cream – mometasone furoate–was so successful that the patients in the research …
Read more on Science Codex
This is really interesting, You’re a very skilled blogger.
I’ve joined your rss feed and look forward to seeking more of your wonderful
post. Also, I have shared your web site in my social networks!